The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it buy, with a mean price target of $18.
Dole plc
DOLE · the NYSE · USD · Market cap $1.2B · 32,027 employees
Dole plc engages in sourcing, production, distribution, and marketing of fresh fruits and vegetables worldwide.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-16
Screened 2026-09-16 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Dole plc holds its Markdown at $13.10. Consolidating, no directional conviction, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $13.10 |
| Valuation | 17.70 trailing · 8.84 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.63 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 28.32% | Below 33% | Interest-bearing debt is just 28.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.15% | Below 33% | Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit. | Pass |
| Receivables | 21.64% | Below 49% | Money owed to the company is 21.6% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.15% | Below 5% | Only 0.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 63.4% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +31% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFresh fruit supply chains hide thin margins everywhere
Walk into any supermarket and the bananas and pineapples sit on the shelves as if they arrived without effort. Dole moves that produce from farms in Latin America and Africa through its three regional segments to shelves worldwide. Revenue is growing at 12 percent, yet the business posts a zero profit margin and an 8 percent return on equity.
The shares trade at a forward multiple of 9.7 times with a 48 percent gap to our fair value of $21.41. That gap looks tempting on paper, but zero margins and unknown competitive protection leave little room for error once input costs or weather shocks appear. Analyst targets sit at $17, offering scant support for the current price.
Currency swings, seasonal harvests and thin pricing power all sit inside an agricultural model that rarely compounds capital well. The ethical screen is clear, yet the operating numbers still fail to justify ownership today.
Analysis, not advice.
| Forward P/E | 8.8xexpensive even after accounting for its growth |
| Trailing P/E | 17.7xreasonably valued |
| EPS, trailing | 0.74 |
| EPS, forward | 1.48 |
| Revenue growth | +2.9%slow but positive growth |
| Profit margin | 0.6%barely profitable |
| Return on equity | 6.9%a modest return on shareholder capital |
| FCF yield | 12.09% |
| Dividend yield | 237.00% |
| Debt to equity | 0.99moderate, manageable leverage |
| Current ratio | 1.28adequate liquidity, worth monitoring |
| Beta | 0.63steadier than the market |
| Short interest, float | 0.05% |
| 52-week range | 12.52 - 16.57 |
| Market cap | $1.2B |
| Employees | 32,027 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Ireland and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDOLE trades on the NYSE (the company is based in Ireland). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it buy, with a mean price target of $18.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it buy, with a mean price target of $18.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.21 | -6.5% | · | $935 | -6.5% |
| 2 months | $15.69 | -9.3% | · | $907 | -9.3% |
| 3 months | $14.32 | -0.6% | $0.09 | $1,000 | 0.0% |
| 6 months | $15.20 | -6.4% | $0.09 | $941 | -5.9% |
| 1 year | $13.64 | +4.3% | $0.09 | $1,049 | +4.9% |
| 2 years | $11.71 | +21.5% | $0.49 | $1,257 | +25.7% |
| 3 years | $13.03 | +9.2% | $0.81 | $1,154 | +15.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DOLE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.